{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:02:03Z","timestamp":1791147723625,"version":"4.1.0"},"reference-count":42,"publisher":"American Diabetes Association","issue":"8","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,8,1]]},"abstract":"<jats:p>We have recently identified a small phosphoprotein, P20, as a common intracellular target for insulin and several of its antagonists, including amylin, epinephrine, and calcitonin gene-related peptide. These hormones elicit phosphorylation of P20 at its different sites, producing three phosphorylated isoforms: S1 with an isoelectric point (pI) value of 6.0, S2 with a pI value of 5.9, and S3 with a pI value of 5.6 (FEBS Letters 457:149\u2013152 and 462:25\u201330, 1999). In the current study, we showed that P20 is one of the most abundant phosphoproteins in rat extensor digitorum longus (EDL) muscle. Insulin and amylin antagonize each other\u2019s actions in the phosphorylation of this protein in rat EDL muscle. Insulin inhibits amylin-evoked phosphorylation of S2 and S3, whereas amylin decreases insulin-induced phosphorylation of S1. In rats made insulin resistant by dexamethasone treatment, levels of the phosphoisoforms S2 and S3, which were barely detectable in healthy rats in the absence of hormone stimulation, were significantly increased. Moreover, the ability of insulin to inhibit amylin-evoked phosphorylation of these two isoforms was greatly attenuated. These results suggested that alterations in the phosphorylation of P20 might be associated with insulin resistance and that P20 could serve as a useful marker to dissect the cellular mechanisms of this disease.<\/jats:p>","DOI":"10.2337\/diabetes.50.8.1821","type":"journal-article","created":{"date-parts":[[2007,3,6]],"date-time":"2007-03-06T19:04:22Z","timestamp":1173207862000},"page":"1821-1827","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":26,"title":["Alteration in Phosphorylation of P20 Is Associated With Insulin Resistance"],"prefix":"10.2337","volume":"50","author":[{"given":"Yu","family":"Wang","sequence":"first","affiliation":[{"name":"School of Biological Sciences, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Xu","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiming","family":"Ye","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W.","family":"Kraegen","sequence":"additional","affiliation":[{"name":"Garvan Institute of Medical Research, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Tse","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth J.S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, University of Auckland, Auckland, New Zealand"},{"name":"Department of Medicine, School of Medicine, University of Auckland, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031207153078300_R1","doi-asserted-by":"crossref","unstructured":"Moller DE, Flier JS: Insulin resistance: mechanisms, syndromes, and implications. N Engl J Med\u2008325:938\u2013948, 1991","DOI":"10.1056\/NEJM199109263251307"},{"key":"2022031207153078300_R2","doi-asserted-by":"crossref","unstructured":"Reaven GM: Pathophysiology of insulin resistance in human disease. Physiol Rev\u200875:473\u2013486, 1995","DOI":"10.1152\/physrev.1995.75.3.473"},{"key":"2022031207153078300_R3","doi-asserted-by":"crossref","unstructured":"Hunter SJ, Garvey WT: Insulin action and insulin resistance: diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am J Med\u2008105:331\u2013345, 1998","DOI":"10.1016\/S0002-9343(98)00300-3"},{"key":"2022031207153078300_R4","doi-asserted-by":"crossref","unstructured":"Kahn BB: Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell\u200892:593\u2013596, 1998","DOI":"10.1016\/S0092-8674(00)81125-3"},{"key":"2022031207153078300_R5","doi-asserted-by":"crossref","unstructured":"Folli F, Saad MJA, Backer JM, Kahn CR: Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest\u200892:1787\u20131794, 1993","DOI":"10.1172\/JCI116768"},{"key":"2022031207153078300_R6","doi-asserted-by":"crossref","unstructured":"Bjornholm M, Kawano Y, Lehtihet M, Zierath JR: Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes\u200846:524\u2013527, 1997","DOI":"10.2337\/diabetes.46.3.524"},{"key":"2022031207153078300_R7","doi-asserted-by":"crossref","unstructured":"Peraldi P, Spiegelman B: TNF-alpha and insulin resistance: summary and future prospects. Mol Cell Biochem\u2008182:169\u2013175, 1998","DOI":"10.1007\/978-1-4615-5647-3_18"},{"key":"2022031207153078300_R8","doi-asserted-by":"crossref","unstructured":"Boden G: Free fatty acids (FFA), a link between obesity and insulin resistance. Front Biosci\u20083:D169\u2013D175, 1998","DOI":"10.2741\/A272"},{"key":"2022031207153078300_R9","doi-asserted-by":"crossref","unstructured":"Cooper GJS, Leighton B, Dimitriadis GD, Parry-Billings M, Kowalchuk JM, Howland K, Rothbard JB, Willis AC, Reid KBM: Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc Natl Acad Sci U S A\u200885:7763\u20137766, 1988","DOI":"10.1073\/pnas.85.20.7763"},{"key":"2022031207153078300_R10","doi-asserted-by":"crossref","unstructured":"Leighton B, Cooper GJ: Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature\u2008335:632\u2013635, 1988","DOI":"10.1038\/335632a0"},{"key":"2022031207153078300_R11","doi-asserted-by":"crossref","unstructured":"Bjorntorp P: Neuroendocrine perturbations as a cause of insulin resistance. Diabetes Metab Res Rev\u200815:427\u2013441, 1999","DOI":"10.1002\/(SICI)1520-7560(199911\/12)15:6<427::AID-DMRR68>3.0.CO;2-C"},{"key":"2022031207153078300_R12","doi-asserted-by":"crossref","unstructured":"Frontoni S, Choi SB, Banduch D, Rossetti L: In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle. Diabetes\u200840:568\u2013573, 1991","DOI":"10.2337\/diabetes.40.5.568"},{"key":"2022031207153078300_R13","doi-asserted-by":"crossref","unstructured":"Molina JM, Cooper GJS, Leighton B, Olefsky JM: Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes\u200839:260\u2013265, 1990","DOI":"10.2337\/diabetes.39.2.260"},{"key":"2022031207153078300_R14","doi-asserted-by":"crossref","unstructured":"Castle AL, Kuo CH, Ivy JL: Amylin influences insulin-stimulated glucose metabolism by two independent mechanisms. Am J Physiol\u2008274:E6\u2013E12, 1998","DOI":"10.1152\/ajpendo.1998.274.1.E6"},{"key":"2022031207153078300_R15","doi-asserted-by":"crossref","unstructured":"Young AA, Wang MW, Cooper GJ: Amylin injection causes elevated plasma lactate and glucose in the rat. FEBS Lett\u2008291:101\u2013104, 1991","DOI":"10.1016\/0014-5793(91)81113-M"},{"key":"2022031207153078300_R16","doi-asserted-by":"crossref","unstructured":"Young DA, Deems RO, Deacon RW, Mcintosh RH, Foley JE: Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro. Am J Physiol\u2008259:E457\u2013E461, 1990","DOI":"10.1152\/ajpendo.1990.259.3.E457"},{"key":"2022031207153078300_R17","doi-asserted-by":"crossref","unstructured":"Hettiarachchi M, Chalkley S, Furler SM, Choong YS, Heller M, Cooper GJS, Kraegen EW: Rat amylin-(8\u201337) enhances insulin action and alters lipid metabolism in normal and insulin resistant rats. Am J Physiol\u2008273:E859\u2013E867, 1997","DOI":"10.1152\/ajpendo.1997.273.5.E859"},{"key":"2022031207153078300_R18","doi-asserted-by":"crossref","unstructured":"Gebre-Medhin S, Mulder H, Pekny M, Westermark G, Tornell J, Westermark P, Sundler F, Ahren B, Betsholtz C: Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun\u2008250:271\u2013277, 1998","DOI":"10.1006\/bbrc.1998.9308"},{"key":"2022031207153078300_R19","doi-asserted-by":"crossref","unstructured":"Enoki S, Mitsukawa T, Takemura J, Nakazato M, Aburaya J, Toshimori H, Matsukara S: Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract\u200815:97\u2013102, 1992","DOI":"10.1016\/0168-8227(92)90074-2"},{"key":"2022031207153078300_R20","doi-asserted-by":"crossref","unstructured":"Moller DE, Bjorbaek C, Vidal-Puig A: Candidate genes for insulin resistance. Diabetes Care\u200819:396\u2013400, 1996","DOI":"10.2337\/diacare.19.4.396"},{"key":"2022031207153078300_R21","unstructured":"DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Review\u20085:177\u2013269, 1997"},{"key":"2022031207153078300_R22","doi-asserted-by":"crossref","unstructured":"Kahn CR: Insulin action, diabetogenes, and the cause of type 2 diabetes. Diabetes\u200843:1066\u20131084, 1994","DOI":"10.2337\/diab.43.8.1066"},{"key":"2022031207153078300_R23","doi-asserted-by":"crossref","unstructured":"Wang Y, Xu A, Cooper GJS: Amylin evokes phosphorylation of P20 in rat skeletal muscle. FEBS Lett\u2008457:149\u2013152, 1999","DOI":"10.1016\/S0014-5793(99)01029-7"},{"key":"2022031207153078300_R24","doi-asserted-by":"crossref","unstructured":"Wang Y, Xu A, Pearson RB, Cooper GJ: Insulin and insulin antagonists evoke phosphorylation of P20 at serine 157 and serine 16, respectively in rat skeletal muscle. FEBS Lett\u2008462:25\u201330, 1999","DOI":"10.1016\/S0014-5793(99)01496-9"},{"key":"2022031207153078300_R25","doi-asserted-by":"crossref","unstructured":"Kato K, Goto S, Inaguma Y, Hasegawa K, Morishita R, Asano T: Purification and characterization of a 20-kDa protein that is highly homologous to alpha B crystallin. J Biol Chem\u2008269:15302\u201315309, 1994","DOI":"10.1016\/S0021-9258(17)36606-1"},{"key":"2022031207153078300_R26","doi-asserted-by":"crossref","unstructured":"Oakes ND, Cooney GJ, Camilleri S, Chisholm DJ, Kraegen EW: Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes\u200846:1768\u20131774, 1997","DOI":"10.2337\/diabetes.46.11.1768"},{"key":"2022031207153078300_R27","doi-asserted-by":"crossref","unstructured":"Robinson R, Robinson LJ, James DE, Lawrence JC Jr: Glucose transport in L6 myoblasts overexpressing GLUT1 and GLUT4. J Biol Chem\u2008268:22119\u201322126, 1993","DOI":"10.1016\/S0021-9258(20)80656-5"},{"key":"2022031207153078300_R28","doi-asserted-by":"crossref","unstructured":"Inaguma Y, Hasegawa K, Kato K, Nishida Y: cDNA cloning of a 20-kDa protein (p20) highly homologous to small heat shock proteins: developmental and physiological changes in rat hindlimb muscles. Gene\u2008178:145\u2013150, 1996","DOI":"10.1016\/0378-1119(96)00356-3"},{"key":"2022031207153078300_R29","doi-asserted-by":"crossref","unstructured":"Woodrum DA, Brophy CM, Wingard CJ, Beall A, Rasmussen H: Phosphorylation events associated with cyclic nucleotide-dependent inhibition of smooth muscle contraction. Am J Physiol\u2008277:H931\u2013H939, 1999","DOI":"10.1152\/ajpheart.1999.277.3.H931"},{"key":"2022031207153078300_R30","doi-asserted-by":"crossref","unstructured":"Beall AC, Kato K, Goldenring JR, Rasmussen H, Brophy CM: Cyclic nucleotide-dependent vasorelaxation is associated with the phosphorylation of a small heat shock-related protein. J Biol Chem\u2008272:11283\u201311287, 1997","DOI":"10.1074\/jbc.272.17.11283"},{"key":"2022031207153078300_R31","doi-asserted-by":"crossref","unstructured":"Brophy CM, Lamb S, Graham A: The small heat shock-related protein-20 is an actin-associated protein. J Vasc Surg\u200829:326\u2013333, 1999","DOI":"10.1016\/S0741-5214(99)70385-X"},{"key":"2022031207153078300_R32","doi-asserted-by":"crossref","unstructured":"Niwa M, Kozawa O, Matsuno H, Kato K, Uematsu T: Small molecular weight heat shock-related protein, HSP20, exhibits an anti-platelet activity by inhibiting receptor-mediated calcium influx. Life Sci\u200866:L7\u2013L12, 2000","DOI":"10.1016\/S0024-3205(99)00566-4"},{"key":"2022031207153078300_R33","doi-asserted-by":"crossref","unstructured":"Cooper GJS: Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr Rev\u200815:163\u2013201, 1994","DOI":"10.1210\/edrv-15-2-163"},{"key":"2022031207153078300_R34","doi-asserted-by":"crossref","unstructured":"Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, Main MJ, Foord SM, Sexton PM: Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol\u200856:235\u2013242, 1999","DOI":"10.1124\/mol.56.1.235"},{"key":"2022031207153078300_R35","doi-asserted-by":"crossref","unstructured":"Andrews RC, Walker BR: Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci\u200896:513\u2013523, 1999","DOI":"10.1042\/cs0960513"},{"key":"2022031207153078300_R36","doi-asserted-by":"crossref","unstructured":"Giorgino F, Almahfouz A, Goodyear LJ, Smith RJ: Glucocorticoid regulation of insulin receptor and substrate IRS-1 tyrosine phosphorylation in rat skeletal muscle in vivo. J Clin Invest\u200891:2020\u20132030, 1993","DOI":"10.1172\/JCI116424"},{"key":"2022031207153078300_R37","doi-asserted-by":"crossref","unstructured":"Dimitriadis G, Leighton B, Parry-Billings M, Sasson S, Young M, Krause U, Bevan S, Piva T, Wegener G, Newsholme EA: Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle. Biochem J\u2008321:707\u2013712, 1997","DOI":"10.1042\/bj3210707"},{"key":"2022031207153078300_R38","doi-asserted-by":"crossref","unstructured":"Pieber TR, Stein DT, Ogawa A, Alam T, Ohneda M, McCorkle K, Chen L, McGarry JD, Unger RH: Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. Am J Physiol\u2008265:E446\u2013E453, 1993","DOI":"10.1152\/ajpendo.1993.265.3.E446"},{"key":"2022031207153078300_R39","doi-asserted-by":"crossref","unstructured":"Kao AW, Noda Y, Johnson JH, Pessin JE, Saltiel AR: Aldolase mediates the association of F-actin with the insulin-responsive glucose transporter GLUT4. J Biol Chem\u2008274:17742\u201317747, 1999","DOI":"10.1074\/jbc.274.25.17742"},{"key":"2022031207153078300_R40","doi-asserted-by":"crossref","unstructured":"Tsakiridis T, Vranic M, Klip A: Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J Biol Chem\u2008269:29934\u201329942, 1994","DOI":"10.1016\/S0021-9258(18)43971-3"},{"key":"2022031207153078300_R41","doi-asserted-by":"crossref","unstructured":"Moyers JS, Bilan PJ, Reynet C, Kahn CR: Overexpression of Rad inhibits glucose uptake in cultured muscle and fat cells. J Biol Chem\u2008271:23111\u201323116, 1996","DOI":"10.1074\/jbc.271.38.23111"},{"key":"2022031207153078300_R42","doi-asserted-by":"crossref","unstructured":"Condorelli G, Vigliotta G, Iavarone C, Caruso M, Tocchetti CG, Andreozzi F, Cafieri A, Tecce MF, Formisano P, Beguinot L, Beguinot F: PED\/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J\u200817:3858\u20133866, 1998","DOI":"10.1093\/emboj\/17.14.3858"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/50\/8\/1821\/369566\/1821.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/50\/8\/1821\/369566\/1821.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:11:01Z","timestamp":1667405461000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/50\/8\/1821\/11281\/Alteration-in-Phosphorylation-of-P20-Is-Associated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,1]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2001,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diabetes.50.8.1821","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,1]]}}}